Delivery Order SPE2DB24D3014-SPE2DB26FKRUV
- Not listed
- The Defense Logistics Agency awarded a $1,160.87 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on August 1, 2025, with completion scheduled for August 4, 2025. This firm fixed-price contract represents a non-competitive set-aside procurement and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract, which is non-set-aside, is scheduled for completion by July 28, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a $1,568.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mounjaro 10 mg/0.5 ml pens (0.5 ml units). This is a non-set-aside, competitively awarded contract with a completion date of August 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $32,650.80 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on September 19, 2025, with completion expected by September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded a delivery order valued at $4,086.19 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on May 27, 2025, with an ultimate completion date of May 28, 2025. This competitive, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used in the treatment of type 2 diabetes, reflecting...
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens with a ceiling value of $1,890.31. This firm fixed-price delivery order, which is not associated with a set-aside designation, is set to complete by August 28, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, and...
- The Defense Logistics Agency awarded a delivery order valued at $3,437.98 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2...
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB26FKRUVDelivery Order
The Defense Logistics Agency awarded a $1,706.93 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 24, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control in patients with type 2 diabetes, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical products to support military healthcare requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages this comprehensive IDC to supply a broad range of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The parent IDC encompasses global pharmaceutical support across multiple therapeutic domains, enabling the company to efficiently fulfill individual delivery orders such as this one for specialized diabetes medications needed by the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/23/25 |